University College London Hospitals
uclh.nhs.ukTotal trials
62
Active
7
Phase 3
4
Total enrollment
524,598
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Prostate Cancer10
- Tinnitus3
- Breast Cancer3
- Colorectal Cancer2
- Critical Illness2
- Sepsis2
- Sexual Dysfunction2
- Epilepsy2
Frequently asked questions about University College London Hospitals
- How many clinical trials does University College London Hospitals have on ClinicalTrials.gov?
- University College London Hospitals is listed as the lead sponsor on 62 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University College London Hospitals's trials are in Phase 3?
- 4 of University College London Hospitals's trials are in Phase 3.
- What therapeutic areas does University College London Hospitals focus on?
- University College London Hospitals's most-studied conditions on ClinicalTrials.gov are Prostate Cancer, Tinnitus, Breast Cancer, Colorectal Cancer, Critical Illness.